China Universal Asset Management Co., Ltd. Cyma Bay Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 May 21, 2024	BUY	$12.63 - $24.47 $165,629 - $320,899	13,114 New	13,114 $309,000
Q4 2023 Jan 23, 2024	BUY	$12.63 - $24.47 $133,852 - $259,333	10,598 Added 421.22%	13,114 $310,000
Q3 2023 May 21, 2024	BUY	$10.86 - $17.62 $13,444 - $21,813	1,238 Added 96.87%	2,516 $37,000
Q3 2023 Oct 30, 2023	BUY	$10.86 - $17.62 $13,444 - $21,813	1,238 Added 96.87%	2,516 $38,000
Q2 2023 May 21, 2024	SELL	$7.47 - $10.95 $29 - $43	-4 Reduced 0.31%	1,278 $13,000
Q2 2023 Jul 27, 2023	SELL	$7.47 - $10.95 $29 - $43	-4 Reduced 0.31%	1,278 $14,000
Q1 2023 May 21, 2024	BUY	$5.88 - $9.59 $2,481 - $4,046	422 Added 49.07%	1,282 $11,000
Q1 2023 Apr 27, 2023	BUY	$5.88 - $9.59 $2,481 - $4,046	422 Added 49.07%	1,282 $11,000
Q4 2022 May 21, 2024	BUY	$3.22 - $6.27 $2,769 - $5,392	860 New	860 $5,000
Q4 2022 Jan 31, 2023	BUY	$3.22 - $6.27 $215 - $420	67 Added 8.45%	860 $5,000
Q3 2022 Oct 21, 2022	BUY	$2.77 - $4.25 $2,196 - $3,370	793 New	793 $3,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account